Efficacy and safety of highly purified, doubly virus‐inactivated VWF/FVIII concentrates in inherited von Willebrand’s disease: results of an Italian cohort study on 120 patients characterized by bleeding severity score

Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis

1995 • 1,117 citations

Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor

2006 • 1,083 citations

A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD)

2006 • 510 citations

Treatment of von Willebrand's Disease

2004 • 483 citations

High Plasma Concentration of Factor VIIIc Is a Major Risk Factor for Venous Thromboembolism

2000 • 479 citations

Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study

2003 • 215 citations

Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study

2002 • 187 citations

Guidelines for the diagnosis and management of von Willebrand disease in Italy

2002 • 153 citations

Venous Thromboembolism in Von Willebrand Disease

2002 • 141 citations

Efficacy and Safety of the Factor VIII/von Willebrand Factor Concentrate, Haemate-P/Humate-P: Ristocetin Cofactor Unit Dosing in Patients with von Willebrand Disease

2002 • 118 citations

Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII/VWF concentrate (Humate‐P^®)

2004 • 102 citations

The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977–2007)

2007 • 95 citations

Clinical use of Haemate(R) P in inherited von Willebrand's disease: a cohort study on 100 Italian patients

2007 • 79 citations

Evidence-based diagnosis of type 1 von Willebrand disease: a Bayes theorem approach

2008 • 69 citations

Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate‐P^®): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy

2003 • 66 citations

Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.

2003 • 65 citations

Clinical efficacy of highly purified, doubly virus‐inactivated factor VIII/von Willebrand factor concentrate (Fanhdi^®) in the treatment of von Willebrand disease: a retrospective clinical study

2002 • 58 citations

Management of inherited von Willebrand disease in 2007

2007 • 55 citations

Highly purified VWF/FVIII concentrates in the treatment and prophylaxis of von Willebrand disease: the PRO.WILL Study

2007 • 51 citations

Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys

2005 • 50 citations

Elevated factor VIII is a risk factor for idiopathic venous thromboembolism in Canada – is it necessary to define a new upper reference range for factor VIII?

2005 • 46 citations

Efficacy of factor VIII/von Willebrand factor concentrate Alphanate^® in preventing excessive bleeding during surgery in subjects with von Willebrand disease

2008 • 41 citations

Fanhdi^®, efficacy and safety in von Willebrand’s disease: prospective international study results

2007 • 29 citations

Clinical efficacy in bleeding and surgery in von Willebrand patients treated with Fanhdi^® a highly purified, doubly inactivated FVIII/VWF concentrate

2008 • 23 citations

The safety of plasma-derived von Willebrand/factor VIII concentrates in the management of inherited von Willebrand disease

2009 • 16 citations

von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.

1999 • 11 citations

Incidence and Determinants of Bleeding in Different Types of von Willebrand Disease: Results of the First Prospective Multicenter Study on 814 Italian Patients.

2007 • 9 citations

[Development and characterization of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)].

1996 • 6 citations